What does a negative Hepatitis B (HBV) titre after vaccination indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Negative Hepatitis B Titre After Vaccination

A negative hepatitis B titre (anti-HBs <10 mIU/mL) after vaccination indicates a non-response to the vaccine series, and revaccination with a complete 3-dose series is recommended for optimal protection against HBV infection. 1

Understanding Negative HBV Titres

A negative hepatitis B titre after vaccination means that the person has not developed adequate protective antibodies (anti-HBs <10 mIU/mL) in response to the vaccine. This can occur for several reasons:

  • Primary non-response to the initial vaccine series
  • Waning immunity years after successful vaccination
  • Immunocompromised state affecting immune response
  • Technical issues with vaccine administration or storage

Management Algorithm for Negative HBV Titres

1. For Individuals with Anti-HBs <10 mIU/mL After Primary Series:

  • Revaccinate with a complete 3-dose series on the appropriate schedule 1
  • Perform anti-HBs testing 1-2 months after completing the second series
  • If anti-HBs remains <10 mIU/mL after revaccination:
    • Test for HBsAg to rule out chronic infection
    • If HBsAg negative, consider the person susceptible to HBV infection
    • Counsel about precautions to prevent HBV infection and need for HBIG post-exposure prophylaxis for any known exposure 1

2. Special Considerations Based on Risk Category:

Healthcare Personnel (HCP):

  • Test for anti-HBs upon hire if previously vaccinated
  • Provide additional doses for those with anti-HBs <10 mIU/mL
  • After exposure to HBsAg-positive source:
    • If documented non-responder to 3-dose series: administer 1 dose HBIG and begin second vaccine series
    • If documented non-responder to two 3-dose series: administer 2 doses HBIG, 1 month apart 1

Immunocompromised Persons:

  • May need annual testing to assess anti-HBs concentrations
  • Revaccination recommended when anti-HBs <10 mIU/mL
  • Higher risk of HBV reactivation if anti-HBc positive 1

Infants Born to HBsAg-Positive Mothers:

  • If anti-HBs <10 mIU/mL, revaccinate with a single dose and retest in 1-2 months
  • If still <10 mIU/mL, complete second 3-dose series and retest 1

Immune Memory and Protection

Despite negative titres, many vaccinated individuals may still have protection due to immune memory:

  • Studies show that 67-76% of individuals with anti-HBs <10 mIU/mL years after vaccination demonstrate an anamnestic response when given a booster dose 1
  • Nearly all immunocompetent persons who initially responded to the primary series remain protected from clinical hepatitis B disease even if antibody levels decline below 10 mIU/mL 1, 2
  • Breakthrough infections in vaccinated persons are typically transient and asymptomatic; chronic infections are rare 1

Important Clinical Considerations

  • Anti-HBs ≥10 mIU/mL is considered protective and indicates successful immunization 1, 3
  • Immunocompetent persons with documented adequate response do not need further periodic testing or booster doses 1
  • Different assays may have different cutoff values for anti-HBs; refer to the specific test's package insert 1
  • Some individuals with negative commercial assay results may still have low-level antibodies that provide protection 4

Common Pitfalls to Avoid

  1. Don't assume complete susceptibility: Even with anti-HBs <10 mIU/mL, immune memory may provide protection in immunocompetent individuals who previously responded to vaccination.

  2. Don't ignore risk factors: Immunocompromised persons, hemodialysis patients, and healthcare workers require different management approaches when titres are negative.

  3. Don't delay revaccination in high-risk individuals with negative titres, as they remain vulnerable to infection until adequate antibody levels are achieved.

  4. Don't forget to test for HBsAg in non-responders to rule out chronic infection, especially in high-risk populations.

  5. Don't recommend universal booster doses for all individuals with waning antibody levels, as this is not currently supported by evidence for immunocompetent persons 2.

By following these evidence-based recommendations, clinicians can appropriately manage patients with negative hepatitis B titres after vaccination to ensure optimal protection against HBV infection and its complications.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Hepatitis B Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is hepatitis B serology necessary in patients who have received the hepatitis B (HB) vaccine?
At what anti-HBs (antibody to hepatitis B surface antigen) titer should I repeat hepatitis B vaccination?
Should I re-initiate the entire hepatitis B (HBV) vaccination series if I was previously vaccinated in 1996 but now have no detectable antibodies?
What are the management options for a low or negative hepatitis B (HB) titer?
What is the recommended hepatitis B (HB) titre for Hepatitis B Immunoglobulin (HBIG) administration?
What is the workup for a patient presenting with right calf pain suspected to be Deep Vein Thrombosis (DVT)?
What is the best imaging test for the pancreas?
What is the recommended oxygen administration protocol for actively seizing patients?
What medication is most appropriate for a 56-year-old male with Hypertension (HTN), obesity, family history of Hyperlipidemia, and elevated Low-Density Lipoprotein (LDL) levels, with a Blood Pressure (BP) of 150/96 mmHg and LDL of 82 mg/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question